心力衰竭的治疗,一般经过治疗病因,控制诱因,减轻心脏负担,增强心肌收缩力以及消除水钠潴留等综合治疗后,临床上大部分心力衰竭可以得到纠正。但仍有相当部分的病人,经过上述的综合治疗后,心力衰竭仍然得不到满意的控制,如顽固性心衰。近年来由于对血管扩张剂的作用研究有了新的进展,尤其是随着对血液动力学的作用认识加深,而临床上应用逐渐扩大。我们在应 The treatment of heart failure, the general treatment of etiology, control incentives, reduce the burden on the heart, enhance myocardial contractility and eliminate water and sodium retention and other comprehensive treatment, the clinical most of the heart failure can be corrected. However, there are still a considerable number of patients who, after the above comprehensive treatment, still can not get satisfactory control of heart failure, such as refractory heart failure. In recent years, due to the role of vasodilators research has made new progress, especially with the understanding of the role of hemodynamics deepen, and gradually expand the clinical application. We should be